These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6161654)

  • 1. In vivo binding of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(1,3-dichloro-2-propyl) phosphate to macromolecules of mouse liver, kidney and muscle.
    Morales NM; Matthews HB
    Bull Environ Contam Toxicol; 1980 Jul; 25(1):34-8. PubMed ID: 6161654
    [No Abstract]   [Full Text] [Related]  

  • 2. Diester metabolites of the flame retardant chemicals, tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl) phosphate in the rat: identification and quantification.
    Lynn RK; Wong K; Dickinson RG; Gerber N; Kennish JM
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):351-60. PubMed ID: 7394328
    [No Abstract]   [Full Text] [Related]  

  • 3. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
    Gold MD; Blum A; Ames BN
    Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal oxidative degradation studies of phosphate esters.
    Paciorek KJ; Kratzer RH; Kaufman J; Nakahara JH; Christos T; Hartstein AM
    Am Ind Hyg Assoc J; 1978 Aug; 39(8):633. PubMed ID: 696625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity and hepatotoxicity of tris(2,3-dibromopropyl)phosphate in the rat.
    Söderlund E; Dybing E; Nelson SD
    Toxicol Appl Pharmacol; 1980 Nov; 56(2):171-81. PubMed ID: 7466817
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the genotoxic properties of tris(2,3-dibromopropyl)phosphate and tris(1,3-dichloro-2-propyl)phosphate in a battery of short-term bioassays.
    Brusick D; Matheson D; Jagannath DR; Goode S; Lebowitz H; Reed M; Roy G; Benson S
    J Environ Pathol Toxicol; 1979 Dec; 3(1-2):207-26. PubMed ID: 121137
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolism and disposition of tris(1,3-dichloro-2-propyl) phosphate (Fyrol FR-2) in the rat.
    Nomeir AA; Kato S; Matthews HB
    Toxicol Appl Pharmacol; 1981 Mar; 57(3):401-13. PubMed ID: 7222047
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.
    Dybing E; Søderlund E
    Arch Toxicol Suppl; 1980; 4():219-22. PubMed ID: 6933906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tris(2,3-dibromopropyl) phosphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1979 Oct; 20():575-88. PubMed ID: 397179
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo covalent binding of the kidney toxicant and carcinogen tris(2,3-dibromopropyl)-phosphate.
    Söderlund EJ; Nelson SD; Dybing E
    Toxicology; 1981; 21(4):291-304. PubMed ID: 7302950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding.
    Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E
    Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
    Lynn RK; Garvie-Gould C; Wong K; Kennish JM
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
    [No Abstract]   [Full Text] [Related]  

  • 14. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat.
    Lynn RK; Wong K; Garvie-Gould C; Kennish JM
    Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and disposition of the flame retardant tris(2,3-dibromopropyl)phosphate in the rat.
    Nomeir AA; Matthews HB
    Toxicol Appl Pharmacol; 1983 Mar; 67(3):357-69. PubMed ID: 6845365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing in-vitro estrogenic effects of currently-used flame retardants.
    Krivoshiev BV; Dardenne F; Covaci A; Blust R; Husson SJ
    Toxicol In Vitro; 2016 Jun; 33():153-62. PubMed ID: 26979758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E; Hyman J; Rosenkranz HS
    Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flame retardant tris (2, 3-dibromopropyl) phosphate: alteration of human cellular DNA.
    Gutter B; Rosenkranz HS
    Mutat Res; 1977 Sep; 56(1):89-90. PubMed ID: 593298
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo and in vitro binding of 1,2-dibromoethane and 1,2-dichloroethane to macromolecules in rat and mouse organs.
    Arfellini G; Bartoli S; Colacci A; Mazzullo M; Galli MC; Prodi G; Grilli S
    J Cancer Res Clin Oncol; 1984; 108(2):204-13. PubMed ID: 6206071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible macromolecular binding of the flame retardant tris-(2, 3-dibromopropyl)phosphate in vitro and in vivo.
    Dybing E; Söderlund EJ; Nelson SD
    Dev Toxicol Environ Sci; 1980; 8():265-8. PubMed ID: 7308025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.